Supernus Pharmaceuticals, Inc.
A maker of brain and nervous-system medicines, Supernus develops and sells branded treatments for ADHD, Parkinson's disease, epilepsy, and postpartum depression—brands like Qelbree, GOCOVRI, Trokendi XR, and ZURZUVAE. It began in 2005 as a spin-out of Shire Laboratories, founded by Jack Khattar, who then bought the very business he had led. Its name comes from Latin for "from above," a fitting label for a company born out of the lab it once ran.
Sold 167.0K
Sold 232.0K
Sold 223.3K
Bought 1.10M · Sold 600.0K
Bought 4.40M
Granted 16.2K · Bought 4.40M · Sold 608.8K
Granted 1.85M · Bought 22.2K · Sold 985.3K
Bought 1.10M
Bought 1.10M
Granted 78.2K · Bought 4.40M · Sold 44.2K
Granted 84.7K · Bought 2.5K · Sold 37.5K
Granted 74.9K · Bought 13.0K
Granted 8.6K · Sold 8.6K
Granted 87.0K · Bought 5.0K · Sold 31.6K
Granted 255.0K · Sold 265.0K
Granted 315.0K · Bought 8.0K · Sold 275.6K
Granted 85.0K · Sold 57.7K
Bought 35.0K
Granted 27.0K
Bought 15.0K
Granted 84.0K · Sold 61.5K
Granted 498.8K · Sold 482.0K
Granted 18.9K · Sold 927
Granted 177.8K · Sold 177.8K
Granted 33.4K · Sold 11.8K
Granted 7.5K · Sold 8.9K
Granted 9.8K · Sold 9.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Barris Peter J10% owner · 15 transactions | — | 13.03Mas of Nov 2015 | — | — | 167.0K |
| Sandell Scott D10% owner · 15 transactions | — | 12.93Mas of Nov 2015 | — | — | 232.0K |
| Baskett Forest10% owner · 14 transactions | — | 12.92Mas of Nov 2015 | — | — | 223.3K |
| Isaly Samuel D +2 co-filers10% owner · 12 transactions | — | 7.63Mas of Feb 2013 | — | 1.10M | 600.0K |
| Barris Peter J +9 co-filers10% owner · 2 transactions | — | 6.24Mas of May 2012 | — | 4.40M | — |
| Barrett M JamesDirector · 40 transactions | — | 4.48Mas of Mar 2016 | 16.2K | 4.40M | 608.8K |
| Khattar Jack A.President, CEO, Director · 162 transactions | — | 4.40M | 1.85M | 22.2K | 985.3K |
| Kolluri Krishna Kittu10% owner · 10 transactions | — | 3.84Mas of Nov 2015 | — | — | — |
| Nea Partners 11 LP10% owner · 6 transactions | — | 3.82Mas of Nov 2015 | — | — | — |
| New Enterprise Associates 11 LP10% owner · 2 transactions | — | 3.82Mas of Nov 2015 | — | — | — |
| Abingworth Management LTD10% owner · 2 transactions | — | 3.60Mas of May 2012 | — | 1.10M | — |
| Sheffery Michael BDirector · 6 transactions | — | 2.77Mas of May 2012 | — | 1.10M | — |
| Newhall Charles W IIIDirector · 23 transactions | — | 124.1K | 78.2K | 4.40M | 44.2K |
| Martin Tami TillotsonSr. V.P., Regulatory Affairs · 24 transactions | — | 86.9Kas of Feb 2024 | 84.7K | 2.5K | 37.5K |
| Siebert John MDirector · 15 transactions | — | 84.1Kas of Feb 2024 | 74.9K | 13.0K | — |
| Bryan Jones W.VP of Business Development · 5 transactions | — | 74.7Kas of Mar 2015 | 8.6K | — | 8.6K |
| Hudson Frederick M.Director · 18 transactions | — | 60.4K | 87.0K | 5.0K | 31.6K |
| Schwabe Stefan K.F.Executive Vice President & CMO · 17 transactions | — | 49.1Kas of Dec 2020 | 255.0K | — | 265.0K |
| Patrick Gregory SSr. VP Chief Financial Officer · 37 transactions | — | 44.5Kas of Nov 2020 | 315.0K | 8.0K | 275.6K |
| Gemayel GeorgesDirector · 17 transactions | — | 36.1K | 85.0K | — | 57.7K |
| Bigham MichaelDirector · 4 transactions | — | 35.0Kas of Mar 2013 | — | 35.0K | — |
| Barlow CarroleeDirector · 6 transactions | — | 27.0K | 27.0K | — | — |
| Nuerge William A.Director · 1 transaction | — | 23.8Kas of Jun 2017 | — | 15.0K | — |
| Mottola FrankSVP, Chief Tech. Ops. Officer · 48 transactions | — | 18.4K | 84.0K | — | 61.5K |
| Bhatt Padmanabh P.Sr. VP of IP, CSO · 117 transactions | — | 17.5K | 498.8K | — | 482.0K |
| Rubin JonathanSVP, Chief Medical Officer · 30 transactions | — | 13.3K | 18.9K | — | 927 |
| Vaughn VictorSr. VP of Sales & Marketing · 21 transactions | — | 9.3Kas of Apr 2018 | 177.8K | — | 177.8K |
| Dec Timothy CSenior Vice-President & CFO · 34 transactions | — | 8.1K | 33.4K | — | 11.8K |
| Horich William ToddSVP, Commercial Operations · 8 transactions | — | 4.8K | 7.5K | — | 8.9K |
| Sensenig BethanyDirector · 5 transactions | — | 4.5K | 9.8K | — | 9.8K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: +12.31M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.